The Role of Botulinum Toxin Therapy in Chronic Pain Management
Chronic pain and severe forms of headache, such as chronic migraine and tension-type headache, significantly reduce patients' quality of life. Traditional treatment methods do not always provide sufficient relief, especially if the condition is accompanied by medication overuse. In recent years, botulinum toxin therapy has established itself as a highly effective method of preventive treatment [2, 4]. According to clinical data, the administration of OnabotulinumtoxinA using specific protocols (e.g., PREEMPT) allows for a significant reduction in the frequency of attacks and the intensity of pain syndrome [7, 8].
Mechanisms of Action of Botulinum Toxin in Migraine
The effectiveness of botulinum toxin therapy for chronic pain is due not only to muscle relaxation but also to its influence on the biochemical mechanisms of pain transmission. Studies show that after injections of botulinum toxin type A, the levels of key pain and inflammation markers in patients' saliva decrease, such as calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating polypeptide (PACAP) [6]. Furthermore, the procedure helps reduce stress levels, which is confirmed by the dynamics of biomarkers in saliva, including cortisol and alpha-amylase [8]. Scientists also observe changes at the molecular level, including the modulation of receptor expression associated with the chronification of pain [4].
Clinical Results and Comorbid Conditions
Numerous observations demonstrate pronounced positive dynamics with regular procedures. For example, Migraine Disability Assessment (MIDAS) scores improve significantly after the first injection courses, demonstrating a progressive reduction in the severity of the patient's condition [5].
- Reduction in the total number of headache days per month [1].
- Decrease in the need for acute pain medications [1].
- Relief of symptoms of comorbid pathologies, such as bruxism (teeth grinding), which directly contributes to a reduction in pain sensations in the maxillofacial region [3].
- Improvement in psychological state and reduction in anxiety levels [1].
Combined Approach and Reducing Procedural Discomfort
Since the classic protocol for botulinum toxin therapy in migraine requires between 31 and 40 injections per session, patients may experience temporary procedural discomfort or post-injection headache [2]. To address this issue, modern medicine is exploring innovative methods of adjunctive therapy, including remote electrical neuromodulation, which helps reduce acute procedural pain without the use of additional medications [2]. Furthermore, botulinum toxin therapy is successfully comparable in effectiveness to other physiotherapy methods, such as low-level laser therapy, allowing for the selection of individualized treatment regimens for each patient [1].
Sources
- 1. Botulinum toxin A (BT-A) versus low-level laser therapy (LLLT) in chronic migraine treatment: a comparison
- 2. Remote electrical neuromodulation for reducing procedural pain in patients with chronic migraine receiving onabotulinumtoxinA injections
- 3. OnabotulinumtoxinA to Prevent Chronic Migraine with Comorbid Bruxism: Real-World Data from the GRASP Study Group
- 4. Changes in P2X4 receptor expression following AbobotulinumtoxinA treatment in patients with chronic migraine: A case series study
- 5. Botulinum Toxin in Migraine Treatment
- 6. Assessment of Pain-Related Biomarkers in Migraine and Tension Headache Patients Pre- and Post-Botulinum Toxin Therapy
- 7. Onabotulinum toxin A (Botox) for chronic migraine treatment: an Italian experience
- 8. Evaluation of Stress Biomarkers in individuals with Migraine or Tension-Type headached before and after Botulinum Toxin Injection
Disclaimer: The information presented in this article is for reference purposes only and does not replace an in-person consultation with a neurologist.